GEHC - GE Healthcare Corp Long-Term Indebtedness

Graphic logo of GE HealthCare Inc. (GEHC)

AI integration into imaging and a substantial order backlog are driving growth for GE HealthCare (GEHC). Robust global logistics for the delivery of complex equipment ensure stable margins. The development strategy relies on the implementation of smart algorithms in MRI and a transition toward service subscriptions. The business's long-term debt level demonstrates the current parameter 10.44, allowing for an assessment of the company's overall debt load.

GE Healthcare Corp (GEHC) - Company Long-Term Debt from 04/28/2023 to 10/30/2026

GE Healthcare Corp - analytical breakdowns and key metrics (GEHC)

- market price and analyst price targets:
Stock Price gehealthcare.com|GEHC - Analyst Consensus Forecast
- market capitalization statistics:
Market Capitalization GE HealthCare|GEHC - Total Company Value
- company book value details:
Equity per Share GE HealthCare|GEHC - Company Book Value|Market-to-Book Ratio gehealthcare.com|GEHC - Aggregate Company Assets
- debt level and financial liquidity data:
Total Debt to Capital Coefficient GE HealthCare|GEHC - Long-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio GE HealthCare Inc.|GEHC - Company Aggregate Debts|Debts to Net Assets GE HealthCare|GEHC - Company Long-Term Debts|Company Current Liabilities GE HealthCare|Intermediate Coverage Ratio gehealthcare.com
- earnings and valuation multiples indicators:
GEHC - Company Net Income
Summary company analytics:GEHC gehealthcare.com
Signature product of GE HealthCare Technologies Inc.

The implementation of circular economy principles in the production of medical systems at GE HealthCare (GEHC) is directly reflected in the analysis of the company's long-term debt. This indicator aggregates all credit obligations with a maturity of more than one year, capturing the total amount of borrowed capital. An increase in this metric may signify either the financing of ecological modernization or an intensifying debt burden. It is critical for investors to distinguish between investment expansion and the risk of declining liquidity.

Who GE HealthCare competes with

Company Long-Term Debts abbott.com ABT|Thermo Fisher - Company Long-Term Debts|Long-Term Indebtedness Mettler-Toledo (MTD)|Waters Corp. (WAT) - Company Long-Term Debt|Company Long-Term Indebtedness TECH|Company Long-Term Debt Bruker Corporation|Long-Term Debt azenta.com AZTA|Company Long-Term Debt Varex Imaging Corporation (VREX)|Long-Term Debt Volume Semler Scientific Inc|Butterfly iQ - Company Long-Term Liabilities|Amount of Long-Term Liabilities MLAB (Mesa Laboratories Corp.)|Quantum-Si - Company Long-Term Debts|Long-Term Debt Volume nanox.vision NNOX|QTRX: Company Long-Term Debts|Company Long-Term Liabilities 908 Devices Inc|Company Long-Term Liabilities CV|MXCT: Company Long-Term Loans and Borrowings|Company Long-Term Debt Rapid Micro Biosystems (RPID)|Company Long-Term Liabilities seer.bio SEER|Company Long-Term Debts HYPR (Hyperfine)|FONAR Corp. (FONR) - Long-Term Debt|Daxor Corp. - Company Long-Term Debts|MDAI (Spectral AI Inc.) - Company Long-Term Indebtedness|VIVS: Company Long-Term Debts|ACON - Long-Term Debt Volume|AKYA (Akoya Biosciences Inc) - Company Long-Term Debts|Company Long-Term Liabilities ThermoGenesis Holdings, Inc. (THMO)|Company Long-Term Debts TLIS|Company Long-Term Debts T2 Biosystems Inc (TTOO)